Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Functional characterization of CNOT3 variants identified in familial adenomatous polyposis adenomas.

Delacruz RGC, Sandoval IT, Chang K, Miller BN, Reyes-Uribe L, Borras E, Lynch PM, Taggart MW, Hawk ET, Vilar E, Jones DA.

Oncotarget. 2019 Jun 11;10(39):3939-3951. doi: 10.18632/oncotarget.27003. eCollection 2019 Jun 11.

2.

Mind the Gap: Precision Oncology and Its Potential to Widen Disparities.

Huey RW, Hawk E, Offodile AC 2nd.

J Oncol Pract. 2019 Jun;15(6):301-304. doi: 10.1200/JOP.19.00102. Epub 2019 May 21. No abstract available.

PMID:
31112478
3.

Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung.

Sivakumar S, San Lucas FA, Jakubek YA, McDowell TL, Lang W, Kallsen N, Peyton S, Davies GE, Fukuoka J, Yatabe Y, Zhang J, Futreal PA, Fowler J, Fujimoto J, Ehli EA, Hawk ET, Wistuba II, Kadara H, Scheet P.

EBioMedicine. 2019 Apr;42:296-303. doi: 10.1016/j.ebiom.2019.03.020. Epub 2019 Mar 21.

4.

Cancer-Related Risk Perceptions and Beliefs in Texas: Findings from a 2018 Population-Level Survey.

Cunningham SA, Yu R, Shih T, Giordano S, McNeill LH, Rechis R, Peterson SK, Cinciripini P, Foxhall L, Hawk E, Shete S.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):486-494. doi: 10.1158/1055-9965.EPI-18-0846. Epub 2019 Jan 30.

PMID:
30700446
5.

Real-Time Interrogation of Aspirin Reactivity, Biochemistry, and Biodistribution by Hyperpolarized Magnetic Resonance Spectroscopy.

Zacharias NM, Ornelas A, Lee J, Hu J, Davis JS, Uddin N, Pudakalakatti S, Menter DG, Karam JA, Wood CG, Hawk ET, Kopetz S, Vilar E, Bhattacharya PK, Millward SW.

Angew Chem Int Ed Engl. 2019 Mar 22;58(13):4179-4183. doi: 10.1002/anie.201812759. Epub 2019 Feb 20.

6.

AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health.

Lippman SM, Abate-Shen C, Colbert Maresso KL, Colditz GA, Dannenberg AJ, Davidson NE, Disis ML, DuBois RN, Szabo E, Giuliano AR, Hait WN, Lee JJ, Kensler TW, Kramer BS, Limburg P, Maitra A, Martinez ME, Rebbeck TR, Schmitz KH, Vilar E, Hawk ET.

Cancer Prev Res (Phila). 2018 Dec;11(12):735-778. doi: 10.1158/1940-6207.CAPR-18-0421.

PMID:
30530635
7.

Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2.

Chang K, Willis JA, Reumers J, Taggart MW, San Lucas FA, Thirumurthi S, Kanth P, Delker DA, Hagedorn CH, Lynch PM, Ellis LM, Hawk ET, Scheet PA, Kopetz S, Arts J, Guinney J, Dienstmann R, Vilar E.

Ann Oncol. 2018 Oct 1;29(10):2061-2067. doi: 10.1093/annonc/mdy337.

PMID:
30412224
8.

Perspectives on Strengthening Cancer Research and Control in Latin America Through Partnerships and Diplomacy: Experience of the National Cancer Institute's Center for Global Health.

Frech S, Muha CA, Stevens LM, Trimble EL, Brew R, Perin DP, Luciani S, Mohar A, Piñeros M, Vidaurre T, Morgan DR, Hawk ET, Schmeler KM, Foxhall LE, Rabadan-Diehl C, Duran D, Rendler-Garcia M, Cazap EL, Santini L, Zoss W, Delgado LB, Pearlman PC, Given L, Hohman K, Lopez MS, Kostelecky B.

J Glob Oncol. 2018 Sep;4:1-11. doi: 10.1200/JGO.17.00149.

9.

Bioactive lipid metabolism in platelet "first responder" and cancer biology.

Kanikarla-Marie P, Kopetz S, Hawk ET, Millward SW, Sood AK, Gresele P, Overman M, Honn K, Menter DG.

Cancer Metastasis Rev. 2018 Sep;37(2-3):439-454. doi: 10.1007/s10555-018-9755-8. Review.

PMID:
30112590
10.

A Pilot Study Evaluating Organochlorine and Organophosphate Pesticide Exposure in Children and Adolescents of Mexican Descent Residing in Hidalgo County, Texas.

Hernandez M, Hernández-Valero MA, García-Prieto C, Patterson DG, Hajek RA, Recinos I, Lopez DS, Li Y, Jones LA, Hawk E.

J Immigr Minor Health. 2019 Aug;21(4):751-760. doi: 10.1007/s10903-018-0791-9.

PMID:
30066057
11.

Building a health communication brand for University of Texas System tobacco control.

Mackert M, Case K, Lazard A, Oh J, Hughes Wagner J, Hawk E, Cofer J, Hurst A, Elerian N, Lakey D.

J Am Coll Health. 2019 May-Jun;67(4):291-298. doi: 10.1080/07448481.2018.1469504. Epub 2019 Mar 25.

PMID:
29952736
12.

Molecular mechanisms of the preventable causes of cancer in the United States.

Golemis EA, Scheet P, Beck TN, Scolnick EM, Hunter DJ, Hawk E, Hopkins N.

Genes Dev. 2018 Jul 1;32(13-14):868-902. doi: 10.1101/gad.314849.118. Epub 2018 Jun 26. Review.

13.

Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome.

Chang K, Taggart MW, Reyes-Uribe L, Borras E, Riquelme E, Barnett RM, Leoni G, San Lucas FA, Catanese MT, Mori F, Diodoro MG, You YN, Hawk ET, Roszik J, Scheet P, Kopetz S, Nicosia A, Scarselli E, Lynch PM, McAllister F, Vilar E.

JAMA Oncol. 2018 Aug 1;4(8):1085-1092. doi: 10.1001/jamaoncol.2018.1482.

14.

NSAIDs to Prevent Breast Cancer Recurrence? An Unanswered Question.

Hawk E, Maresso KC, Brown P.

J Natl Cancer Inst. 2018 Sep 1;110(9):927-928. doi: 10.1093/jnci/djy049. No abstract available.

15.

MD Anderson's Population Health Approaches to Cancer Prevention.

Foxhall L, Moreno M, Hawk E.

Tex Med. 2018 Feb 1;114(2):34-41.

PMID:
29393960
16.

Project ECHO: A Telementoring Program for Cervical Cancer Prevention and Treatment in Low-Resource Settings.

Lopez MS, Baker ES, Milbourne AM, Gowen RM, Rodriguez AM, Lorenzoni C, Mwaba C, Msadabwe SC, Tavares JH, Fontes-Cintra G, Zucca-Matthes G, Callegaro-Filho D, Ramos-Martin D, Thiago de Carvalho I, Coelho R, Marques RM, Chulam T, Pontremoli-Salcedo M, Nozar F, Fiol V, Maza M, Arora S, Hawk ET, Schmeler KM.

J Glob Oncol. 2016 Oct 5;3(5):658-665. doi: 10.1200/JGO.2016.005504. eCollection 2017 Oct.

17.

Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.

Sivakumar S, Lucas FAS, McDowell TL, Lang W, Xu L, Fujimoto J, Zhang J, Futreal PA, Fukuoka J, Yatabe Y, Dubinett SM, Spira AE, Fowler J, Hawk ET, Wistuba II, Scheet P, Kadara H.

Cancer Res. 2017 Nov 15;77(22):6119-6130. doi: 10.1158/0008-5472.CAN-17-1605. Epub 2017 Sep 26.

18.

Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention.

Ornelas A, Zacharias-Millward N, Menter DG, Davis JS, Lichtenberger L, Hawke D, Hawk E, Vilar E, Bhattacharya P, Millward S.

Cancer Metastasis Rev. 2017 Jun;36(2):289-303. doi: 10.1007/s10555-017-9675-z. Review.

19.

Platelet "first responders" in wound response, cancer, and metastasis.

Menter DG, Kopetz S, Hawk E, Sood AK, Loree JM, Gresele P, Honn KV.

Cancer Metastasis Rev. 2017 Jun;36(2):199-213. doi: 10.1007/s10555-017-9682-0. Review.

20.

Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic.

Davis JS, Lee HY, Kim J, Advani SM, Peng HL, Banfield E, Hawk ET, Chang S, Frazier-Wood AC.

Open Heart. 2017 Apr 28;4(1):e000550. doi: 10.1136/openhrt-2016-000550. eCollection 2017.

21.

Mutational Heterogeneity in APC and KRAS Arises at the Crypt Level and Leads to Polyclonality in Early Colorectal Tumorigenesis.

Gausachs M, Borras E, Chang K, Gonzalez S, Azuara D, Delgado Amador A, Lopez-Doriga A, San Lucas FA, Sanjuan X, Paules MJ, Taggart MW, Davies GE, Ehli EA, Fowler J, Moreno V, Pineda M, You YN, Lynch PM, Lazaro C, Navin NE, Scheet PA, Hawk ET, Capella G, Vilar E.

Clin Cancer Res. 2017 Oct 1;23(19):5936-5947. doi: 10.1158/1078-0432.CCR-17-0821. Epub 2017 Jun 23.

22.

The somatic mutation landscape of premalignant colorectal adenoma.

Lin SH, Raju GS, Huff C, Ye Y, Gu J, Chen JS, Hildebrandt MAT, Liang H, Menter DG, Morris J, Hawk E, Stroehlein JR, Futreal A, Kopetz S, Mishra L, Wu X.

Gut. 2018 Jul;67(7):1299-1305. doi: 10.1136/gutjnl-2016-313573. Epub 2017 Jun 12.

23.

Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma.

Hassan MM, Botrus G, Abdel-Wahab R, Wolff RA, Li D, Tweardy D, Phan AT, Hawk E, Javle M, Lee JS, Torres HA, Rashid A, Lenzi R, Hassabo HM, Abaza Y, Shalaby AS, Lacin S, Morris J, Patt YZ, Amos CI, Khaderi SA, Goss JA, Jalal PK, Kaseb AO.

Clin Gastroenterol Hepatol. 2017 Nov;15(11):1791-1799. doi: 10.1016/j.cgh.2017.05.036. Epub 2017 Jun 1.

24.

Building trust and diversity in patient-centered oncology clinical trials: An integrated model.

Hurd TC, Kaplan CD, Cook ED, Chilton JA, Lytton JS, Hawk ET, Jones LA.

Clin Trials. 2017 Apr;14(2):170-179. doi: 10.1177/1740774516688860. Epub 2017 Feb 7. Review.

PMID:
28166647
25.

Assessment of Compliance With Texas Legislation Banning Indoor UV Tanning by Minors.

Tripp MK, Gershenwald JE, Davies MA, Garcia J, Gritz ER, Hawk ET, Peterson SK.

JAMA Dermatol. 2017 Feb 1;153(2):228-229. doi: 10.1001/jamadermatol.2016.4068. No abstract available.

26.

Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates.

Chitsazzadeh V, Coarfa C, Drummond JA, Nguyen T, Joseph A, Chilukuri S, Charpiot E, Adelmann CH, Ching G, Nguyen TN, Nicholas C, Thomas VD, Migden M, MacFarlane D, Thompson E, Shen J, Takata Y, McNiece K, Polansky MA, Abbas HA, Rajapakshe K, Gower A, Spira A, Covington KR, Xiao W, Gunaratne P, Pickering C, Frederick M, Myers JN, Shen L, Yao H, Su X, Rapini RP, Wheeler DA, Hawk ET, Flores ER, Tsai KY.

Nat Commun. 2016 Aug 30;7:12601. doi: 10.1038/ncomms12601.

27.

Cancer prevention in developing countries: a vision for preserving health in Mexico.

DePinho RA, Hawk E.

Salud Publica Mex. 2016 Apr;58(2):93-6. No abstract available.

PMID:
27557366
28.

Cancer Prevention Recommendations: Impact of Adherence.

Maresso KC, Hawk E.

Semin Oncol Nurs. 2016 Aug;32(3):306-13. doi: 10.1016/j.soncn.2016.05.010. Epub 2016 Jul 29. Review.

PMID:
27539284
29.

Introduction.

Mahon SM, Hawk E.

Semin Oncol Nurs. 2016 Aug;32(3):185-6. doi: 10.1016/j.soncn.2016.05.001. Epub 2016 Jul 29. No abstract available.

PMID:
27539274
30.

Ernest Hawk Discusses the NCI-Designated Cancer Centers' Joint Statement on the HPV Vaccine.

Hawk ET.

Oncology (Williston Park). 2016 Jul;30(7):599-600. No abstract available.

31.

Genomic Landscape of Colorectal Mucosa and Adenomas.

Borras E, San Lucas FA, Chang K, Zhou R, Masand G, Fowler J, Mork ME, You YN, Taggart MW, McAllister F, Jones DA, Davies GE, Edelmann W, Ehli EA, Lynch PM, Hawk ET, Capella G, Scheet P, Vilar E.

Cancer Prev Res (Phila). 2016 Jun;9(6):417-27. doi: 10.1158/1940-6207.CAPR-16-0081. Epub 2016 May 24.

32.

Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention.

Umar A, Steele VE, Menter DG, Hawk ET.

Semin Oncol. 2016 Feb;43(1):65-77. doi: 10.1053/j.seminoncol.2015.09.010. Epub 2015 Sep 10. Review.

PMID:
26970125
33.

Aspirin for Cancer Prevention: One Step Closer.

Vilar E, Maresso KC, Hawk ET.

JAMA Oncol. 2016 Jun 1;2(6):770-1. doi: 10.1001/jamaoncol.2015.6395. No abstract available.

PMID:
26939883
34.

Germline Genetic Variants in the Wnt/β-Catenin Pathway as Predictors of Colorectal Cancer Risk.

Hildebrandt MA, Reyes ME, Lin M, He Y, Nguyen SV, Hawk ET, Wu X.

Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):540-6. doi: 10.1158/1055-9965.EPI-15-0834. Epub 2016 Jan 25.

35.

When "Effective" Prevention Agents Fail to Elicit Anticipated Effects: Challenges in Trial Design.

Tsai KY, Hawk ET.

Cancer Prev Res (Phila). 2016 Feb;9(2):125-7. doi: 10.1158/1940-6207.CAPR-15-0432. Epub 2015 Dec 29. No abstract available.

36.

Cohort Profile: The MD Anderson Cancer Patients and Survivors Cohort (MDA-CPSC).

Wu X, Hildebrandt MA, Ye Y, Chow WH, Gu J, Cunningham S, Zhao H, Hawk ET, Wagar E, Rodriguez A, Hamilton SR.

Int J Epidemiol. 2016 Jun;45(3):713-713f. doi: 10.1093/ije/dyv317. Epub 2015 Dec 20. No abstract available.

37.

Molecular cancer prevention: Current status and future directions.

Maresso KC, Tsai KY, Brown PH, Szabo E, Lippman S, Hawk ET.

CA Cancer J Clin. 2015 Sep-Oct;65(5):345-83. doi: 10.3322/caac.21287. Epub 2015 Aug 18. Review.

38.

Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma.

Hassan MM, Abdel-Wahab R, Kaseb A, Shalaby A, Phan AT, El-Serag HB, Hawk E, Morris J, Singh Raghav KP, Lee JS, Vauthey JN, Bortus G, Torres HA, Amos CI, Wolff RA, Li D.

Gastroenterology. 2015 Jul;149(1):119-29. doi: 10.1053/j.gastro.2015.03.044. Epub 2015 Mar 30.

39.

An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis.

Lynch PM, Burke CA, Phillips R, Morris JS, Slack R, Wang X, Liu J, Patterson S, Sinicrope FA, Rodriguez-Bigas MA, Half E, Bulow S, Latchford A, Clark S, Ross WA, Malone B, Hasson H, Richmond E, Hawk E.

Gut. 2016 Feb;65(2):286-95. doi: 10.1136/gutjnl-2014-307235. Epub 2015 Mar 19.

40.

Strategy for prevention of cancers of the esophagus.

Akiyama J, Alexandre L, Baruah A, Buttar N, Chandra R, Clark AB, Hart AR, Hawk E, Kandioler D, Kappel S, Krishnadath SK, Sharma A, Singh I, Straub D, Triadafilopoulos G, Umar A, Wolf B.

Ann N Y Acad Sci. 2014 Sep;1325:108-26. doi: 10.1111/nyas.12529.

PMID:
25266020
41.

Should CMS cover lung cancer screening for the fully informed patient?

Volk RJ, Hawk E, Bevers TB.

JAMA. 2014 Sep 24;312(12):1193-4. doi: 10.1001/jama.2014.12709. No abstract available.

42.

Urinary PGE-M in colorectal cancer: predicting more than risk?

Colbert Maresso K, Vilar E, Hawk ET.

Cancer Prev Res (Phila). 2014 Oct;7(10):969-72. doi: 10.1158/1940-6207.CAPR-14-0215. Epub 2014 Jul 28.

43.

Convergence of nanotechnology and cancer prevention: are we there yet?

Menter DG, Patterson SL, Logsdon CD, Kopetz S, Sood AK, Hawk ET.

Cancer Prev Res (Phila). 2014 Oct;7(10):973-92. doi: 10.1158/1940-6207.CAPR-14-0079. Epub 2014 Jul 24. Review.

44.

Telemedicine and telesurgery in cancer care: inaugural conference at MD Anderson Cancer Center.

Satcher RL, Bogler O, Hyle L, Lee A, Simmons A, Williams R, Hawk E, Matin S, Brewster AM.

J Surg Oncol. 2014 Sep;110(4):353-9. doi: 10.1002/jso.23652. Epub 2014 May 29. Review.

PMID:
24889208
45.

Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement.

Hawk ET, Habermann EB, Ford JG, Wenzel JA, Brahmer JR, Chen MS Jr, Jones LA, Hurd TC, Rogers LM, Nguyen LH, Ahluwalia JS, Fouad M, Vickers SM.

Cancer. 2014 Apr 1;120 Suppl 7:1113-21. doi: 10.1002/cncr.28571.

46.

Proceedings of the Indo-U.S. bilateral workshop on accelerating botanicals/biologics agent development research for cancer chemoprevention, treatment, and survival.

Kumar NB, Dhurandhar M, Aggarwal B, Anant S, Daniel K, Deng G, Djeu J, Dou J, Hawk E, Jayaram B, Jia L, Joshi R, Kararala M, Karunagaran D, Kucuk O, Kumar L, Malafa M, Samathanam GJ, Sarkar F, Siddiqi M, Singh RP, Srivastava A, White JD.

Cancer Med. 2013 Feb;2(1):108-15.

47.

Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma.

Xu E, Gu J, Hawk ET, Wang KK, Lai M, Huang M, Ajani J, Wu X.

Carcinogenesis. 2013 Dec;34(12):2750-6. doi: 10.1093/carcin/bgt286. Epub 2013 Aug 29. Erratum in: Carcinogenesis. 2014 Mar;35(3):738.

48.

Adenoma detection in patients undergoing a comprehensive colonoscopy screening.

Raju GS, Vadyala V, Slack R, Krishna SG, Ross WA, Lynch PM, Bresalier RS, Hawk E, Stroehlein JR.

Cancer Med. 2013 Jun;2(3):391-402. doi: 10.1002/cam4.73. Epub 2013 Apr 20.

49.

Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction.

Hassan MM, Kaseb A, Etzel CJ, El-Serag H, Spitz MR, Chang P, Hale KS, Liu M, Rashid A, Shama M, Abbruzzese JL, Loyer EM, Kaur H, Hassabo HM, Vauthey JN, Wray CJ, Hassan BS, Patt YZ, Hawk E, Soliman KM, Li D.

Mol Carcinog. 2013 Nov;52 Suppl 1:E139-47. doi: 10.1002/mc.22057. Epub 2013 Jun 15.

50.

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.

Coxib and traditional NSAID Trialists' (CNT) Collaboration, Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C.

Lancet. 2013 Aug 31;382(9894):769-79. doi: 10.1016/S0140-6736(13)60900-9. Epub 2013 May 30.

Supplemental Content

Support Center